CURE partnered with UCLA Health and Northside Hospital Cancer Institute for an on-demand webinar series on managing side ...

In this on-demand webinar series, CURE partnered with UCLA Health and Northside Hospital Cancer Institute to discuss best ...

In this on-demand webinar series, CURE partnered with UCLA Health and Northside Hospital Cancer Institute to discuss side ...

Researchers have found an association between baseline circulating tumor cell count and survival in metastatic ...

When a dear friend told me he has lung cancer, I opened up and shared my own perspective and experience as a survivor of ...

Ponsegromab increased weight and activity levels in cachexia patients, confirming GDF-15 as a key driver and therapeutic ...

Addressing systemic barriers and implementing policies can reduce disparities in healthcare access and promote equity in ...

Panelists discuss how personal experiences with access- to- care challenges highlight the need for systemic improvements and ...

If approved by the FDA, Darzalex Faspro may be the first treatment for smoldering multiple myeloma as compared to treating the disease once it progresses.

The CAR-T cell therapy Aucatzyl was approved for relapsed or refractory B-cell precursor acute lymphoblastic leukemia based ...

As a patient with chronic lymphocytic leukemia, I recently gleaned three new insights from my oncologist and phlebotomist.

From James Van Der Beek spreading awareness about colorectal cancer at a younger age to Gerry Connolly’s recent esophageal ...